[Improved life expectancy by prevention of atherosclerosis. Results of intervention studies for treatment of lipid metabolism disorders]

Versicherungsmedizin. 1989 Sep 1;41(5):162-5.
[Article in German]

Abstract

An elevated serum cholesterol level is one of the main risk factors for the development of atherosclerosis. In primary and secondary intervention trials it was shown that a reduction of total cholesterol in serum was accompanied by a reduction of the coronary risk: 1 percent decrease of serum cholesterol levels resulted in a reduction of coronary risk by 2 percent. Furthermore an increase of the antiatherogenic HDL cholesterol and lowering serum triglycerides cause a further decrease of the risk for the development of coronary heart disease. By controlled use of antilipidemic diets and drugs a prevention of atherosclerosis is possible resulting in an increase of life quality and expectancy.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / prevention & control*
  • Double-Blind Method
  • Germany, West / epidemiology
  • Humans
  • Hypercholesterolemia / mortality
  • Hypercholesterolemia / prevention & control*
  • Hypolipidemic Agents / therapeutic use
  • Life Expectancy*
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Hypolipidemic Agents